Federated Hermes’s MaxCyte MXCT Stock Holding History

Federated Hermes’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$705	Buy	+1,003	New	+$936	﹤0.01%	2020
2024 Q4	–	Sell	-9,736	Closed	-$37.9K	–	2154
2024 Q3	$37.9K	Buy	9,736 +4,110	+73%	+$17.3K	﹤0.01%	1696
2024 Q2	$22.1K	Sell	5,626 -1,114	-17%	-$4.79K	﹤0.01%	1710
2024 Q1	$28.2K	Buy	+6,740	New	+$31.6K	﹤0.01%	1687
2022 Q4	–	Sell	-3,448	Closed	-$22K	–	2235
2022 Q3	$22K	Buy	3,448 +1,223	+55%	+$6.82K	﹤0.01%	1761
2022 Q2	$11K	Sell	2,225 -986,002	-100%	-$4.86M	﹤0.01%	1822
2022 Q1	$6.91M	Sell	988,227 -349	-0%	-$2.38K	0.02%	701
2021 Q4	$10.1M	Buy	988,576 +295,986	+43%	+$3.18M	0.02%	642
2021 Q3	$8.46M	Buy	+692,590	New	+$10.4M	0.02%	694

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Federated Hermes's MXCT Position: Q1 2026 in Review

Federated Hermes opened a new position in MaxCyte (MXCT) in Q1 2026: 1,003 shares worth $705. The stake represents ﹤0.01% of the portfolio and ranks #2020 among its holdings. This is a return to the name: Federated Hermes previously reported a position in MXCT as recently as Q3 2024.

Federated Hermes first reported a position in MXCT in Q3 2021 and has held it in 9 quarters since. The position peaked at $10.1M in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Federated Hermes held 1,003 shares of MaxCyte worth $705 as of Q1 2026.
MaxCyte was a new Federated Hermes position in Q1 2026.
MaxCyte made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #2020 holding.
Federated Hermes first reported a position in MaxCyte in Q3 2021 and has held it in 9 quarters since.
Federated Hermes's MaxCyte position peaked at $10.1M in Q4 2021.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.